Pharmaceutical News

RSS

Beta blockers linked to increased depression in heart attack patients

All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted earlier this year, this drug is unlikely to be needed for those heart patients who have a normal pumping ability.

11 Nov 2024

Novel bladder cancer treatment gains MHRA approval in the UK

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment of adults with unresectable or metastatic urothelial carcinoma (UC), the most common form of bladder cancer.

9 Nov 2024

Adipo Therapeutics shares results of studies on potential obesity treatment

Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and related metabolic disorders, presented data from two studies at the annual meeting of The Obesity Society in San Antonio.

7 Nov 2024

Many veterans pursue psychedelics for healing or spiritual exploration

Most U.S. military veterans who have used psychedelics reported in a recent study that they pursued the substances for healing or spiritual exploration, and over 80% said they benefited from the experience – even those who had challenging outcomes.

6 Nov 2024

Rice bioengineers uncover why IL-12 immunotherapy loses effectiveness

A team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12) ⎯ a potent immune-boosting protein that holds promise for cancer treatment ⎯ loses effectiveness over time when used as an immunotherapeutic.

6 Nov 2024

Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive cancer therapies.

5 Nov 2024

No evidence Trump’s drug program for terminal patients saved ‘thousands’ of lives

Former President Donald Trump has boasted in recent months about "Right To Try," a law he signed in 2018. It's aimed at boosting terminally ill patients' access to potentially lifesaving medications not yet approved by the Food and Drug Administration.

5 Nov 2024

Celastrol's druggability, molecular targets, and nanocarrier delivery against chronic diseases

Announcing a new publication for Acta Materia Medica journal. Celastrol is an active compound from the root of Tripterygium wilfordii Hook F that shows great potential in the treatment of inflammation, cancer, neurodegeneration, diabetes, and obesity.

5 Nov 2024

Canada’s proactive policies reduce drug shortages far more effectively than the U.S.

Drug-related supply chain issues in Canada were 40% less likely to result in significant drug shortages than in the United States.

4 Nov 2024

Polypharmacy linked to negative health outcomes in older adults with Alzheimer's

Polypharmacy, commonly defined as taking five or more medications daily, is a significant health care concern impacting over 30% of older adults.

1 Nov 2024

Glaucoma medication may help prevent Alzheimer's-related tau build-up

A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in Alzheimer's disease.

1 Nov 2024

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight patients with chronic kidney disease.

31 Oct 2024

Nanoplastics impair antibiotic effectiveness and promote resistance

In a recent study, an international research team with significant involvement from MedUni Vienna has investigated how nanoplastic particles deposited in the body affect the effectiveness of antibiotics.

30 Oct 2024

Radioprotective effects of Licochalcone B against radiation-induced cell damage

Radiation injury poses a serious threat to human health, causing complex and multifaceted damage to cells and tissues. Such injury can be caused by various factors, including nuclear accidents, medical radiation therapy, and space travel.

29 Oct 2024

Unraveling the mechanism of Shufeng Jiedu Capsules in influenza treatment

Shufeng Jiedu Capsules (SFJD), a traditional Chinese medicine preparation, are widely used in the clinical treatment of influenza, yet their mechanism of action remains unclear.

29 Oct 2024

Evosep expanding capabilities with new headquarters to support rising needs in pharma and biotech for proteomics

...

From Evosep 28 Oct 2024

Expanded access to weight-loss drugs could save thousands of lives

Researchers explore the potential benefits of expanding access to novel weight loss drugs to enhance survival rates in overweight and obese individuals.

28 Oct 2024

Bioactive peptides from Chlorella vulgaris for therapeutic applications

Chlorella vulgaris is a green, photosynthetic microalga in the phylum Chlorophyta. The goal of our study was to perform a bioinformatics analysis of Photosystem I P700 chlorophyll a apoprotein A2, one of its photosynthesis-related proteins, and to hunt for potent bioactive peptides.

27 Oct 2024

Tenofovir amibufenamide does not alter lipid levels in patients with chronic hepatitis B

The effect of tenofovir amibufenamide (TMF) on blood lipid profiles in patients with chronic hepatitis B (CHB) remains unclear. This study aimed to explore whether TMF affects blood lipids during 48 weeks in patients with CHB.

26 Oct 2024

New trial shows felzartamab reduces proteinuria in IgA nephropathy patients

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface.

26 Oct 2024

Previous
1
...
9
10
11
12
13
14
15
...
1443
Next

Pharmaceutical News

Beta blockers linked to increased depression in heart attack patients

Novel bladder cancer treatment gains MHRA approval in the UK

Adipo Therapeutics shares results of studies on potential obesity treatment

Many veterans pursue psychedelics for healing or spiritual exploration

Rice bioengineers uncover why IL-12 immunotherapy loses effectiveness

Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

No evidence Trump’s drug program for terminal patients saved ‘thousands’ of lives

Celastrol's druggability, molecular targets, and nanocarrier delivery against chronic diseases

Canada’s proactive policies reduce drug shortages far more effectively than the U.S.

Polypharmacy linked to negative health outcomes in older adults with Alzheimer's

Glaucoma medication may help prevent Alzheimer's-related tau build-up

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Nanoplastics impair antibiotic effectiveness and promote resistance

Radioprotective effects of Licochalcone B against radiation-induced cell damage

Unraveling the mechanism of Shufeng Jiedu Capsules in influenza treatment

Evosep expanding capabilities with new headquarters to support rising needs in pharma and biotech for proteomics

Expanded access to weight-loss drugs could save thousands of lives

Bioactive peptides from Chlorella vulgaris for therapeutic applications

Tenofovir amibufenamide does not alter lipid levels in patients with chronic hepatitis B

New trial shows felzartamab reduces proteinuria in IgA nephropathy patients

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News